Deciphex
Deciphex builds AI-powered digital pathology platforms, Patholytix and Diagnexia, linking expert pathologists worldwide with AI tools for clinical diagnostics and preclinical research.
Deciphex builds AI-powered digital pathology systems that pair a global network of expert pathologists with machine-learning tools to deliver faster and more accurate diagnoses. The company works at the intersection of medicine and technology, with a stated aim of addressing the worldwide shortage of pathologists. Its technology covers medical image analysis, clinical diagnostics and preclinical research, applied through healthcare software platforms.
Two products anchor the offering. Patholytix is a platform for preclinical research in digital pathology. Diagnexia is a clinical diagnostics service that connects clinicians with a global network of pathologists supported by AI tools; the company reports that diagnostic wait times have been cut from months to days. Deciphex serves major pharmaceutical companies and operates across the healthcare, clinical diagnostics, drug development and preclinical research sectors.
The company is headquartered in Dublin, Ireland, with a presence in the United Kingdom, the United States and Canada. Its teams span medicine and technology, and the stated emphasis is on practical, scalable solutions intended to improve patient outcomes and real-world impact.
